Role of nitric oxide in autoimmunity

Clinical Immunology and Immunopathology

Volumn 76, Issue 1 I, 1995, Pages 1-11

  Vladutiu, A O ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0029021275     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1995.1081     Document Type: Review

References (107)

1. Moncada, S., Palmer, R. M. J., and Higgs, E. A., Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142, 1991.
2. Nathan, C., Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064, 1992.
3. Moncada, S., The L-arginine: Nitric oxide pathway. Acta Phys-iol. Scand. 145, 201-227, 1992.
4. Moncada, S., and Higgs, A., The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 2002-2012, 1993.
5. Kiechle, F. L., and Malinski, T., Nitric oxide: Biochemistry, pathophysiology and detection. Am. J. Clin. Pathol. 100, 567-575, 1993.
6. Lowenstein, C. J., Dinerman, J. L., and Snyder, S. H., Nitric oxide: A physiologic messenger. Ann. Intern. Med. 120, 227-237, 1994.
7. Ignarro, L. J., Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res. 65, 1-21, 1989.
8. Fostermann, U., Schmidt, H.H., Pollock, J. S., Sheng, J. A., Mitchell, J. A., Warner, T. D., Nakane, M., and Murad, F., Iso-forms of nitric oxide synthase: Characterization and purification from different cell types. Biochem. Pharmacol. 42, 1849-1857, 1991.
9. Forstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwartz, P., Gath, I., and Kleinert, H., Nitric oxide synthase isozymes-characterization, purification, molecular cloning, and functions. Hypertension 23, 1121-1131, 1994.
10. Nussler, A. K., and Billiar, T. R., Inflammation, immunoregu-lation, and inducible nitric oxide snythase. J. Leukocyte Biol. 54, 171-178, 1993.
11. Van Dervort, A. L., Yan, L., Madara, P. J., Cobb, J. P., Wesley, R. A., Corriveau, C. C, Tropea, M. M., and Danner, R. L., Nitric oxide regulates endotoxin-induced TNF-o production by human neutrophils. J. Immunol. 152, 4102-4109, 1994.
12. Lander, H. M., Sehajpal, P., Levine, D. M., and Novogrodsky, A., Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150, 1509-1516, 1993.
13. Mayhan, W. G., Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5'-diphosphate and bradykinin. Inflammation 16, 295-305, 1992.
14. Magrinat, G., Mason, S. N., Shami, P. J., and Weinberg, J. B., Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood 80, 1880-1884, 1992.
15. Kròncke, K-D., Kolb-Bachofen, V., Berschick, B., Burkart, V., and Kolb, H., Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem. Biophys. Res. Commun. 175, 752-758, 1991.
16. Kaplan, S. S., Billar, T. R., Curran, R. D., Zdziarski, U. E., Simmons, R. L., and Basford, R. E., Inhibition of chemotaxis with 7V-monomethyl-L-arginine: A role for c GMP. Blood 74, 1885-1887, 1989.
17. Stadler, J., Billiar, T. R., Curran, R. D., Sruehr, D. J., Ochoa, J. B., and Simmons, R. L., Effect of exogenous and endogenous nitric oxide on mitochondria! respiration of rat hepatocytes. Am. J. Physiol. 260, C901-C916, 1991.
18. Welsh, N., and Sandier, S., Interleukin-1β induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets. Biochem. Biophys. Res. Commun. 182, 333-340, 1992.
19. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., and Freeman, B. A., Apparent hydroxyl radical production by per-oxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc. Nati. Acad. Sci. USA 87, 1620-1624, 1990.
20. Messmer, U. K., and Brune, B., Modulation of inducible nitric oxide synthase in RINm5F cells. Cell. Signal. 6, 17-24, 1994.
21. Curran, R. D., Billiar, T. R., Stuehr, D. J., Hoffman, K., and Simmons, R., Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J. Exp. Med. 170, 1769-1774, 1989.
22. Lloyd, R. V., Jin, L., Qian, X., Zhang, S., and Scheithauer, B. W., Nitric oxide synthase in the human pituitary gland. Am. J. Pathol. 146, 86-94, 1995.
23. Taylor-Robinson, A., Phillips, R. S., Severn, A., Moncada, S., and Liew, F. Y., The role of Thl and Th2 cells in a rodent malaria infection. Science 260, 1931-1934, 1993.
24. Kirk, S. J., Regan, M. C, and Barbul, A., Cloned murine T lymphocytes synthesize a molecule with the biological characteristics of nitric oxide. Biochem. Biophys. Res. Commun. 173, 660-665, 1990.
25. Bianco, F. J., Ochs, R. L., Schwarz, H., and Lotj, M., Chondro-cytic apoptosis induced by nitric oxide. Am. J. Pathol. 146, 75-80, 1995.
26. Liew, F. Y., Biology of nitric oxide in neuroimmunoregulation. Ann. NYAcad. Sci. 741, 39-45, 1994.
27. Misko, T. P., Moore, W. M., Kasten, T. P., Nickols, G. A., Corbett, J. A., Tilton, R. G., Mc Daniel, M. L., Williamson, J. R., and Currie, M. G., Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233, 119-125, 1936.
28. Andersen, H. U., Jorgensen, K. H., Egeberg, J., Mandrup-Poulsen, T., and Nerup, J., Nicotinamide prevents interleu-kin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 43, 770-777, 1994.
29. Reimers, J. I., Andersen, H. U., and Pociot, F., Nikotinamid og forebyggelse af insulinkraevraevende diabetes mellitus. Rationale, virkingsmekanisme, toksikologi og kliniske erfaringer. ENDIT Gruppe. Ugeskr. Leag. 156, 461-465, 1994.
30. Petros, A., Bennett, D., and Vallance, P., Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338, 1555-1558, 1991.
31. G-Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in guinea pig: Does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Commun. 160, 881-886, 1989.
32. Peterson, D. A., Peterson, D. C, Archer, S., and Weir, E. K., The nonspecificity of specific nitric oxide synthase inhibitors. Biochem. Biophys. Res. Commun. 187, 797-801, 1992.
33. Stuehr, D. J., and Marietta, M. A., Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Nati. Acad. Sci. USA 82, 7738-7742, 1985.
34. Southern, C, Schulster, D., and Green, I. C., Inhibition of insulin secretion by interleukin-1-β and tumor necrosis factor-α via an L-arginine dependent nitric oxide generating mechanism. FEBS Lett. 276, 42-44, 1990.
35. Corbett, J. A., Sweetland, M. A., Wang, J. L., Lancaster, J. R, Jr., and Mc Daniel, M. L., Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Nati. Acad. Sci. USA 90, 1731-1735, 1993.
36. Kroemer, G., and Martinez, A-C., Cytokines and autoimmune disease. Clin. Immunol. Immunopathol. 61, 275-295, 1991.
37. Mulligan, M. S., Hevel, J. M., Marietta, M. A., and Ward, P. A., Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc. Nati. Acad. Sci. USA 88, 6338-6342, 1991.
38. Kolb, H., Kiesel, U., Kroncke, K-D., and Kolb-Bachofen, V., Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor. Life Sci. 49, PL213-217, 1991.
39. Lukic, M. L., Stosic-Grujicic, N., Ostojic, N., Chan, L., and Liew, F. Y., Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice. Biochem. Biophys. Res. Commun. 178, 913-920, 1991.
40. Catanzaro, O. L., Marinaprendes, M. G., Hope, S. I., Zuccollo, A., and Dominguez, A., Streptozotocin-induced hyperglycemia is decreased by nitric oxide inhibition. Braz. J. Med. Biol. Res. 27, 2043-2047, 1994.
41. Holstad, M., and Sandler, S., Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice. Autoimmunity 15, 311-314, 1993.
42. Corbett, J. A., Mikhael, A., Shimizu, J., Frederick, K., Misko, T. P., Mc Daniel, M. L., Kanagawa, O., and Unanue, E. R., Nitric oxide production in islets from non-obese diabetic mice: Aminoguanidine-sensitive and resistant stages in the immuno-logical diabetic process. Proc. Nati. Acad. Sci. USA 90, 8992-8995, 1993.
43. McCartney, Francis, N., Allen, J. B., Mizel, D. E., Albina, J. E., Xie, Q., Nathan, C. F., and Wahl, S, M., Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178, 749-754, 1993.
44. Ialenti, A., Moncada, S., and Di Rosa, M., Modulation of adjuvant arthritis by endogenous nitric oxide. Br. J. Pharmacol. 110, 701-706, 1993.
45. G-monomethyl-L-arginine. J. Exp. Med. 179, 651-660, 1994.
46. Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., and Tilton, R. G., Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93, 2684-2690, 1994.
47. Miller, M. J. S., Sadowska-Krowicka, H., Chotinaruemol, S., Kakkis, J. L., and Clark, D. A., Amelioration of chronic ileitis by nitric oxide synthase inhibition. J. Pharmacol. Exp. Ther. 264, 11-16, 1993.
48. Di Rosa, M., Radomski, M., Canniccio, R., and Moncada, S., Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172, 1246-1252, 1990.
49. Lundberg, J. O. N., Hellström, P. M., Lundberg, J. M., and Alving, K., Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 344, 1673-1674, 1994.
50. Ludowyk, P. A., Hughes, W., Hugh, A., Willenborg, D. O., Rockett, K. A., and Parish, C. R., Astrocytic hypertrophy: An important pathological feature of chronic experimental autoimmune encephalitis in aged rats. J. Neuroimmunol. 48, 121-134, 1993.
51. Lin, R. F., Lin, T-S., Tilton, R G., and Cross, A. H., Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: An electron paramagnetic resonance study. J. Exp. Med. 178, 643-648, 1993.
52. Koprowski, H., Zheng, Y. M., Heber-Katz, E., Fräser, N., Rorke, L., Fu, Z. F., Hanlon, C, and Dietzschold, B., In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Nati. Acad. Sci. USA 90, 3024-3027, 1993.
53. Kleemann, R., Rothe, H., Kolb-Bachofen, V., Xie, Q. W., Nathan, C, Martin, S., and Kolb, H., Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett. 328, 9-12, 1993.
54. Lee, K. U., Nitric oxide produced by macrophages mediates suppression of Con A-induced proliferative responses of splenic leukocytes in the diabetes-prone BB rat. Diabetes 43, 1218-1220, 1994.
55. Stevens, R. B., Ansite, J. D., Sutherland, D. F. R., Coulter, C. F., Wotus, C, and Mills, C. D., Macrophage nitric oxide in autoimmunity. FASEB J. 8, A771, 1994. [Abstract]
56. Farrell, A. J., Blake, D. R., Palmer, R M., and Moncada, S., Increased concentration of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic disease. Ann. Rheum. Dis. 51, 1219, 1992.
57. Weiner, C. P., Lizasoain, I., Baylis, S. A., Knowles, R. G., Charles, I. G., and Moncada, S., Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Nati. Acad. Sci. USA 91, 5212-5216, 1994.
58. Kolb, H., and Kolb-Bachofen, V., Nitric oxide: A pathogenetic factor in autoimmunity. Immunol. Today 13, 157-160, 1992.
59. Kolb, H., Burkart, V., Appels, B., Hanenberg, H., Kantwerk-Funke, G., Kiesel, U., Funda, J., Schraermeyer, U., and Kolb-Bachofen, V., Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J. Autoimmun. 3(Suppl), 117-120, 1990.
60. Lee, K-U., Amano, K., and Yoon, J-W., Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37, 989-991, 1988.
61. Hanenberg, H., Kolb-Bachofen, V., Kantwerk-Funke, G., and Kolb, H., Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of prediabetic BB rats. Diabetologia 32, 126-134, 1989.
62. Lee, K. U., Kim, M. K, Amano, K., Pak, C. Y., Jaworski, M. A., Mehta, J. G., and Yoon, J. W., Preferential infiltration of macrophages during early stages of insulitis in diabetes-prone BB rats. Diabetes 37, 1053-1058, 1988.
63. Brosnan, C. F., Bornstein, M. B., and Bloom, B. R., The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 126, 614-620, 1981.
64. Dang-Vu, A. P., Pisetsky, D. S., and Weinberg, J. B., Functional alterations of macrophages in autoimmune MRL-lpr/lpr mice. J. Immunol. 138, 1757-1761, 1987.
65. Imahori, S. C., and Vladutiu, A. O., Autoimmune granuloma-tous thyroiditis in inbred mice: Resemblance to subacute (de Quervain’s) thyroiditis in man. Proc. Soc. Exp. Biol. Med. 173, 408-416, 1983.
66. Imahori, S. C., and Vladutiu, A. O., Evolution and host-dependent lesions in autoimmune thyroiditis: experimental study in inbred mice. Clin. Immunol. Immunopathol. 33, 87-98, 1984.
67. Vladutiu, A. O., Circulating immune complexes in mice with experimental autoimmune thyroiditis. IRSC Med. Sci. 10, 605, 1982.
68. Vladutiu, A. O., Thyroglobulin antibodies in experimental autoimmune thyroiditis. In "Progress in Autoimmunity" (P. A. Bigazzi, G. Wick, and K. Wicher, Eds.), pp. 241-266, Dekker, New York, 1990.
69. Karesen, R., and Godal, T., Induction of thyroiditis in guinea-pigs by intravenous injection of rabbit-anti-guinea pig thyroglobulin serum. I. Light microscopy study. Immunology 17, 847-861, 1969.
70. Tomazic, V., and Rose, N. R., Autoimmune murine thyroiditis. VII. Induction of the thyroid lesions by passive transfer of immune serum. Clin. Immunol. Immunopathol. 4, 511-518, 1975.
71. Inoue, K., Niessen, N., Milgrom, F., and Albini, B., Transfer of experimental autoimmune thyroiditis by in situ perfusion of thyroids with immune sera. Clin. Immunol. Immunopathol. 66, 11-17, 1993.
72. Conaway, D. H., Giraldo, A. A., David, C. S., and Kong, Y. M., In situ kinetic analysis of thyroid lymphocyte infiltrate in mice developing experimental autoimmune thyroiditis. Clin. Immunol. Immunopathol. 53, 346-353, 1989.
73. Schneenmann, M., Schoeldon, G., Hoefer, S., Blau, N., Guerrero, I., and Schaffner, A., Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167, 1358-1363, 1993.
74. Miossec, P., Acting on the cytokine balance to control autoimmunity and chronic inflammation. Eur. Cytokine Netw. 4, 245-251, 1993.
75. Corbett, J. A., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Jr., and Mc Daniel, M. L., Interleukin-lβ induces the formation of nitric oxide by β-cells purified from rodents islets of Langer-hans: Evidence for the β-cell as a source and site of action of nitric oxide. J. Clin. Invest. 90, 2394-2391, 1992.
76. Nerup, J., Mandrup-Poulsen, T., Helqvist, S., Andersen, H. U., Pociot, F., Reimers, J. I., Cuartero, B. G., Karlsen, A. E., Bierre, U., and Lorenzen, T., On the pathogenesis of IDDM. Diabetologia 37(Suppl. 2), 582-589, 1994.
77. Corbett, J. A., and Mc Daniel, M. L., Does nitric oxide mediate autoimmune destruction of β cells? Possible therapeutic intervention in IDDM. Diabetes 41, 424-429, 1992.
78. Rothe, H., Faust, A., Schade, U., Kleemann, R., Bosse, G., Hibino, T., Martin, S., and Kolb, H., Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 37, 1154-1158, 1994.
79. Schmidt, H. H. H. W., Waarner, T. D., Ishii, K., Sheng, H., and Murad, F., Insulin secretion from pancreatic β cells caused by L-arginine-derived nitrogen oxides. Science 255, 721-723, 1992.
80. Eizirik, D. L., Cagherò, E., Bjorklund, A., and Weist, N., Interleukin-lβ induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages. FEBS Lett. 308, 249-252, 1992.
81. Karlsen, A. E., Boel, E., Cuertero, B., Andersen, H. U., Tobiasen, C, Mandrup-Poulsen, T., and Nerup, J., Detection and cloning of a novel nitric oxide synthase isoform from rat islets and RINm5F cells exposed to IL-1. Diabetologia 36(Suppl 1), A76, 1993.
82. Mandrup-Poulsen, T., Spinas, G. A., Prowse, S. J., Hansen, B. S., Jorgensen, D. W., Brendtzen, K., Nielsen, J. H., and Nerup, J., Islet cytotoxicity of interleukin: Influence of culture conditions and islet donor characteristics. Diabetes 36, 641-647, 1987.
83. Corbett, J. A., Kwon, G., Misko, T. P., Rodi, C. P., and Mc Daniel, M. L., Tyrosine kinase involvement in IL-1-beta-induced expression of i NOS by beta-cells purified from islets of Langerhans. Am. J. Physiol. 267, C48-C54, 1994.
84. Zumsteg, J., Reimers, J. I., Pociot, F., Morch, L., Helqvist, S., Brendel, M., Alejandro, R., Mandrup-Poulsen, T., Dinarello, C. A., and Nerup, J., Differential interleukin-1 receptor antag onism on pancreatic beta and alpha cells: Studies in rodent and human islets and in normal rats. Diabetologia 36, 759-766, 1993.
85. Eizirik, D. L., Pipeleers, D. G., Ling, Z. D., Welsh, N., Hellerström, C, and Andersson, A., Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc. Nati. Acad. Sci. USA 91, 9253-9256, 1994.
86. Hewett, S. J., Corbett, J. A., Mc Daniel, M. L., and Choi, D. W., Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett. 164, 229-232, 1993.
87. Zielasek, J., Tauseh, M., Toyka, K. V., and Härtung, H. P., Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell. Immunol. 141, 111-120, 1992.
88. Mac Micking, J. D., Willenborg, D. O., Weidemann, M. J., Rockett, K. A., and Cowden, W. B., Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory lymphocytes in hyperacute experimental autoimmune encephalomyelitis: Enhancement by soluble products of encephalitogenic T cells. J. Exp. Med. 176, 303-307, 1992.
89. Xenos, E. S., Stevens, R. B., Sutherland, D. E. R., Lokeh, A., Ansite, J. D., Casanova, D., Gores, P. F., and Platt, J. L., The role of nitric oxide in IL-lβ-mediated dysfunction of rodent islets of Langerhans. Transplantation 57, 1208-1212, 1994.
90. Corbett, J. A., Sweatland, M. A., Lancaster, J. R., and Mc Daniel, M. L., A one hour pulse with IL-lβ induces formation of nitric oxide by rat islets of Langerhans: evidence for tyrosine kinase signaling mechanism. FASEB J. 7, 369-374, 1993.
91. Kallman, B., Burkart, V., Kröncke, K-D., Kolb-Bachofen, V., and Kolb, H., Toxicity of chemically generated nitrite oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci. 51, 671-678, 1992.
92. Wiegand, F., Kröncke, K-D., and Kolb-Bachofen, V., Macro-phage-generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets: Prevention by arginine analogs and/or coencapsulated erythrocytes. Transplantation 56, 1206-1212, 1993.
93. Bergmann, L., Kröncke, K-L., Suschek, C, Kolb, H., and Kolb-Bachofen, H., Cytotoxic action of IL-lβ against pancreatic islets is mediated via nitric oxide formation and is inhibited by N°-monomethyl-L-arginine. FEBS Lett. 299, 103-106, 1992.
94. Burkart, V., Kröncke, K. D., Kolb-Bachofen, V., and Kolb, H., Nitric oxide as an inflammatory mediator in insulin-dependent diabetes-mellitus-A new therapeutic target. Clin. Immu-nother. 2, 233-239, 1994.
95. Suarez-Pinzon, W. L., Strynadka, K., Schulz, R., and Rabinovitch, A., Mechanisms of cytokine-induced destruction of rat insulinoma cells-The role of nitric oxide. Endocrinology 134, 1006-1010, 1994.
96. Corbett, J. A., Kwon, G., Turk, J., and Mc Daniel, M. L., IL-1-beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans-Activation of cyclooxygenase by nitric oxide. Biochemistry 32, 13767-13770, 1993.
97. Welsh, N., Eizirik, D. L., and Sandler, S., Nitric oxide and pancreatic beta-cell destruction in insulin dependent diabetes mel-litus-Don’t take NO for an answer. Autoimmunity 18, 285-290, 1994.
98. Eizirik, D. K., Sandier, S., Welsh, N., Cetkovic-Cvrlje, M., Nieman, A., Geller, D. A., Pipeleers, D. G., Bendtzen, K., and Hellerström, C., Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J. Clin. Invest. 93, 1968-1974, 1994.
99. Firestein, G. S., Alvaro-Garcia, J. M., and Maki, R., Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol. 144, 3347-3353, 1990.
100. Reimers, J. I., Bjerre, U., Mandrup-Poulsen, T., and Nerup, J., Interleukin 1-beta induces diabetes and fever in normal rats by nitric oxide via induction of different nitric oxide synthases. Cytokim 6, 512-520, 1994.
101. Nussler, A. K., Renia, L., Pasquetto, V., Miltgen, F., Matile, H., and Mazier, D., In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporosoites, malaria blood parasites or adjuvants. Eur. J. Immunol. 23, 882-887, 1993.
102. G-nitro-L-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK rats. Endocrinology 135, 849-853, 1994.
103. Kröncke, K-D., Funda, J., Berschick, B., Kolb, H., and Kolb-Bachofen, V., Macrophage cytotoxicity towards isolated rat islet cells: Neither lysis nor its protection by nicotinamide are beta-cell specific. Diabetologia 34, 232-238, 1991.
104. Elliott, R. B., and Chase, H. P., Prevention or delay of type I (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia 34, 362-365, 1991.
105. Burkart, V., Bellmann, K., Hartmann, B., Heller, B., Imai, Y., and Kolb, H., Fusidic acid suppresses nitric oxide toxicity in pancreatic islet cells. Biochem. Pharmacol. 48, 1379-1385, 1994.
106. Burkart, V., Imai, Y., Kallmann, B., and Kolb, H., Cyclosporin A protects pancreatic islet cells from nitric oxide-dependent macrophage cytotoxicity. FEBS Lett. 313, 56-58, 1992.
107. Imai, Y., Kolb, H., and Burkart, V., Nitric oxide production from maerophages is regulated by arachidonic acid metabolites. Biochem. Biophys. Res. Commun. 197, 105-109, 1993.